Genomic landscape of FNAs positive for medullary thyroid cancer (MTC) and potential impact on systemic therapy.

Volume: 37, Pages: 6087 - 6087
Published: May 26, 2019
Abstract
6087Background: Systemic therapies targeting specific genomic alterations in advanced MTC are available or under investigation. The Afirma Genomic Sequencing Classifier (GSC) uses RNA sequencing...
Paper Details
Title
Genomic landscape of FNAs positive for medullary thyroid cancer (MTC) and potential impact on systemic therapy.
Published Date
May 26, 2019
Volume
37
Pages
6087 - 6087
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.